Skip to main content
Figure 2 | BMC Nephrology

Figure 2

From: Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study

Figure 2

Proportion of Patients With Controlled Serum Phosphorus Levels. Percentage of patients with controlled serum phosphorus levels at baseline and weeks 12 and 16 of treatment with lanthanum carbonate (intent to treat population). Patients naive to treatment with phosphate binders (n = 105) are not shown. LC = lanthanum carbonate.

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us